Ambient Biosciences
Ann Arbor, US · Delaware corporation
Ambient Biosciences offers a freeze-free, patented stabilization process that makes temperature-sensitive reagents and biomolecules—including antibodies, enzymes, nucleic acids, small molecules, and cells—shelf-stable at room temperature as an alternative to lyophilization and cold-chain storage. It serves life science and biotech companies that produce reagents, enabling ambient shipping, extended shelf life, and reduced cold-chain costs.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$24.3M disclosed across 4 rounds · 2018–2024
▶$4.2MraisedDec 2024 · 9 investors · BiotechnologyRule 506(b)
- Paul MeisterDirector
- Matthew CobbettExecutive Officer
- Pravansu S. MohantyExecutive Officer, Director
- Richard TroyerExecutive Officer
- Jack HoppinDirector
- Craig MansonExecutive Officer
- William U. ParfetDirector
- Offering amount
- $5M
- Amount sold
- $4.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.2MraisedApr 2023 · 8 investors · BiotechnologyRule 506(b)
- William U. ParfetDirector
- Paul MeisterDirector
- Pravansu S. MohantyExecutive Officer
- Offering amount
- $12.2M
- Amount sold
- $9.2M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedDec 2021 · 1 investors · BiotechnologyRule 506(b)
- Carl Le SouefExecutive Officer, Director
- Pravansu S. MohantyExecutive Officer
- Alan TurfeExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedSep 2018 · 1 investors · BiotechnologyRule 506(b)
- Carl Le SouefExecutive Officer, Director
- Pravansu S. MohantyExecutive Officer, Director
- Steve AnnearExecutive Officer
- Offering amount
- $7M
- Amount sold
- $7M
- Finders' fees
- $210K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Ambient Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Ambient Biosciences do?
- Ambient Biosciences offers a freeze-free, patented stabilization process that makes temperature-sensitive reagents and biomolecules—including antibodies, enzymes, nucleic acids, small molecules, and cells—shelf-stable at room temperature as an alternative to lyophilization and cold-chain storage. It serves life science and biotech companies that produce reagents, enabling ambient shipping, extended shelf life, and reduced cold-chain costs.
- How much funding has Ambient Biosciences raised?
- Ambient Biosciences has disclosed $24.3M raised across 4 rounds.
- Where is Ambient Biosciences headquartered?
- Ambient Biosciences is headquartered in Ann Arbor, US.